Logo 1 Logo 2

Clinical Trial Details

Trial ID: L6384
Source ID: NCT01776788
Associated Drug: Insulin Lispro Injection, Exenatide Injection
Title: Effect of Short-Term Intensive Insulin Sequential Exenatide Therapy in Newly Diagnosed Type 2 Diabetic Patients
Acronym:
Status: COMPLETED
Study Results: NO
Results:
Conditions: Diabetes Mellitus, Type 2
Interventions: DRUG: insulin lispro injection, exenatide injection|DRUG: insulin lispro injection
Outcome Measures: Primary: the glycemic remission rate in different groups, one year | Secondary: the improvement of β-cell function in different groups., one year|the time of glycemic remission in different groups, one year
Sponsor/Collaborators: Sponsor: The First Affiliated Hospital of Xiamen University
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases: PHASE4
Enrollment: 156
Study Type: INTERVENTIONAL
Study Designs: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Start Date: 2012-08
Completion Date: 2015-02
Results First Posted:
Last Update Posted: 2015-03-10
Locations: The first afilliated hospital of Xiamen university, Xiamen, Fujian, 361003, China
URL: https://clinicaltrials.gov/show/NCT01776788